Company For Pharma Srl with Fiscal Code 27785320
recorded a turnover of 2024 of
9.565.721,
with a net profit of
269.652
and having an average number of employees of
25.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
For Pharma Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
11.105.530
12.303.922
5.749.878
4.830.992
6.036.767
6.902.844
7.236.867
8.116.051
6.707.167
9.565.721
Total Income - EUR
11.141.032
12.346.629
5.771.744
4.841.068
6.054.380
6.913.404
7.245.819
8.135.970
6.730.415
9.591.250
Total Expenses - EUR
10.552.770
11.111.398
5.217.385
4.541.168
5.559.752
6.385.336
7.053.213
7.825.099
6.586.054
9.275.010
Gross Profit/Loss - EUR
588.262
1.235.231
554.359
299.900
494.628
528.067
192.606
310.871
144.361
316.240
Net Profit/Loss - EUR
485.876
1.033.399
468.038
249.637
419.687
454.884
164.393
266.286
122.118
269.652
Employees
5
8
8
10
14
19
21
23
23
25
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 43.4%, from 6.707.167 euro in the year 2023, to 9.565.721 euro in 2024.
The Net Profit increased by 148.217 euro, from 122.118 euro in 2023, to 269.652 in the last year.
Check the financial reports for the company - For Pharma Srl
Financial Rating - FOR PHARMA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - For Pharma Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - For Pharma Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - For Pharma Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
For Pharma Srl - CUI 27785320
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
224.328
150.946
112.353
123.914
81.077
46.377
98.491
69.692
47.143
65.580
Current Assets
959.593
1.300.267
1.162.052
1.136.285
1.232.758
1.639.900
1.730.113
2.124.410
2.941.913
3.778.143
Inventories
421.860
63.202
251.159
466.660
546.839
607.689
558.348
597.605
787.259
943.710
Receivables
221.161
605.226
462.139
449.653
513.313
761.113
1.036.516
1.326.157
1.621.969
2.339.459
Cash
316.572
631.840
448.754
219.972
172.607
271.098
135.248
200.648
532.685
494.974
Shareholders Funds
885.333
1.033.666
474.925
249.895
664.743
455.132
164.635
266.529
185.675
269.893
Social Capital
225
223
219
215
211
207
202
203
202
201
Debts
305.405
424.027
803.725
1.012.494
649.298
1.240.577
1.662.659
1.927.283
2.807.450
3.583.370
Income in Advance
0
0
0
0
0
0
2.393
1.372
1.885
159
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
3.778.143 euro in 2024 which includes Inventories of
943.710 euro, Receivables of
2.339.459 euro and cash availability of
494.974 euro.
The company's Equity was valued at
269.893 euro, while total Liabilities amounted to
3.583.370 euro.
Equity increased by 85.256 euro, from 185.675 euro in 2023, to 269.893 in 2024.
The Debt Ratio was 93.0% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - For Pharma Srl